About Sanofi-Aventis Administrative Office
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Sanofi
73
Clinical Trials at Sanofi-Aventis Administrative Office
During the past decade, Sanofi-Aventis Administrative Office conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
2001-04-01
2014-12-01
Completed
3,222
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
2002-10-01
2005-08-01
Completed
15,603
PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)
2003-08-01
Completed
Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction
2004-12-01
2007-05-01
Completed
1,257
SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients
2004-05-01
Completed
120
Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis
2004-09-01
2010-07-01
Completed
1,088
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sanofi-Aventis Administrative Office"
#1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator, "Cancer International Research Group (CIRG)" with 3 trials as a collaborator and "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Sanofi-Aventis Administrative Office
According to Clinical.Site data, the most researched conditions in "Sanofi-Aventis Administrative Office" are
"Atrial Fibrillation" (9 trials), "Ascites" (5 trials), "Diabetes Mellitus, Type 2" (5 trials), "Liver Cirrhosis" (5 trials) and "Venous Thromboembolism" (5 trials). Many other conditions were trialed in "Sanofi-Aventis Administrative Office" in a lesser frequency.
Clinical Trials Intervention Types at Sanofi-Aventis Administrative Office
Most popular intervention types in "Sanofi-Aventis Administrative Office" are "Drug" (72 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (13 trials), "Placebo" (12 trials), "Docetaxel" (4 trials), "Enoxaparin sodium" (4 trials) and "Semuloparin sodium" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Sanofi-Aventis Administrative Office
The vast majority of trials in "Sanofi-Aventis Administrative Office" are
63 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Sanofi-Aventis Administrative Office
Currently, there are NaN active trials in "Sanofi-Aventis Administrative Office".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 59 completed trials in Sanofi-Aventis Administrative Office,
undefined suspended trials,
and 14 terminated clinical trials to date.
Out of the total trials that were conducted in Sanofi-Aventis Administrative Office, 0 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 52 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 0 trials that are defined as “Not Applicable".